Hiraki A - Search Results

1

Tumor-specific cytotoxic T lymphocyte responses against chondrosarcoma with HLA haplotype loss restricted by the remaining HLA class I allele.

Hiraki A, Ikeda K, Yoshino T, Kaneshige T, Kiura K, Kunisada T, Fujiwara K, Tanimoto M, Harada M. Hiraki A, et al. Biochem Biophys Res Commun. 2001 Aug 31;286(4):786-91. doi: 10.1006/bbrc.2001.5411. Biochem Biophys Res Commun. 2001. PMID: 11520066

2

Loss of HLA haplotype in lung cancer cell lines: implications for immunosurveillance of altered HLA class I/II phenotypes in lung cancer.

Hiraki A, Kaneshige T, Kiura K, Ueoka H, Yamane H, Tanaka M, Harada M. Hiraki A, et al. Clin Cancer Res. 1999 Apr;5(4):933-6. Clin Cancer Res. 1999. PMID: 10213231

3

Interleukin-12 augments cytolytic activity of peripheral blood mononuclear cells against autologous lung cancer cells in combination with IL-2.

Hiraki A, Kiura K, Yamane H, Nogami N, Tabata M, Takigawa N, Ueoka H, Tanimoto M, Harada M. Hiraki A, et al. Lung Cancer. 2002 Mar;35(3):329-33. doi: 10.1016/s0169-5002(01)00424-x. Lung Cancer. 2002. PMID: 11844609

4

Expression of minor histocompatibility antigen, HA-1, in solid tumor cells.

Fujii N, Hiraki A, Ikeda K, Ohmura Y, Nozaki I, Shinagawa K, Ishimaru F, Kiura K, Shimizu N, Tanimoto M, Harada M. Fujii N, et al. Among authors: hiraki a. Transplantation. 2002 Apr 15;73(7):1137-41. doi: 10.1097/00007890-200204150-00022. Transplantation. 2002. PMID: 11965046

5

High frequency of allele-specific down-regulation of HLA class I expression in lung cancer cell lines.

Hiraki A, Fujii N, Murakami T, Kiura K, Aoe K, Yamane H, Masuda K, Maeda T, Sugi K, Darzynkiewicz Z, Tanimoto M, Harada M. Hiraki A, et al. Anticancer Res. 2004 May-Jun;24(3a):1525-8. Anticancer Res. 2004. PMID: 15274319 Free article.

6

Loss or down-regulation of HLA class I expression at the allelic level in freshly isolated leukemic blasts.

Masuda K, Hiraki A, Fujii N, Watanabe T, Tanaka M, Matsue K, Ogama Y, Ouchida M, Shimizu K, Ikeda K, Tanimoto M. Masuda K, et al. Among authors: hiraki a. Cancer Sci. 2007 Jan;98(1):102-8. doi: 10.1111/j.1349-7006.2006.00356.x. Cancer Sci. 2007. PMID: 17083564 Free PMC article.

7

Genetics of Epstein-Barr virus infection.

Hiraki A, Fujii N, Masuda K, Ikeda K, Tanimoto M. Hiraki A, et al. Biomed Pharmacother. 2001 Sep;55(7):369-72. doi: 10.1016/s0753-3322(01)00084-1. Biomed Pharmacother. 2001. PMID: 11669499 Review.

8

Generation of cytotoxic T lymphocytes against autologous lung cancer cells resistant to apoptosis.

Hiraki A, Ono T, Tanaka M, Kiura K, Ueoka H, Kawai H, Harada M, Nakayama E, Noguchi Y. Hiraki A, et al. Anticancer Res. 2001 Jul-Aug;21(4A):2561-7. Anticancer Res. 2001. PMID: 11724322

9

Characterization of non-small-cell lung cancer cell lines established before and after chemotherapy.

Kawai H, Kiura K, Tabata M, Yoshino T, Takata I, Hiraki A, Chikamori K, Ueoka H, Tanimoto M, Harada M. Kawai H, et al. Among authors: hiraki a. Lung Cancer. 2002 Mar;35(3):305-14. doi: 10.1016/s0169-5002(01)00430-5. Lung Cancer. 2002. PMID: 11844606

10

Primary signet-ring cell carcinoma of the lung with histochemical characterization.

Hiraki A, Ueoka H, Yoshino T, Tabata M, Kiura K, Tanimoto Y, Kamao T, Komoto R, Harada M. Hiraki A, et al. Anticancer Res. 2002 Mar-Apr;22(2B):1079-81. Anticancer Res. 2002. PMID: 12168904

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

187 results

Search Page

Filters